Seeing Is Believing
Currently out of the existing stock ratings of Jonathan Eckard, 16 are a BUY (76.19%), 5 are a HOLD (23.81%).
Analyst Jonathan Eckard, currently employed carries an average stock price target met ratio of 61.9% that have a potential upside of 31.39% achieved within 525 days. Previously, Jonathan Eckard worked at BARCLAYS.
Jonathan Eckard’s has documented 34 price targets and ratings displayed on 3 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ALKS, Alkermes Plc at 29-Jul-2016.
Analyst best performing recommendations are on ALKS (ALKERMES PLC).
The best stock recommendation documented was for ALKS (ALKERMES PLC) at 10/7/2015. The price target of $79 was fulfilled within 78 days with a profit of $19.02 (31.71%) receiving and performance score of 4.07.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$19
$19
1 years 1 months 27 days ago
(27-Sep-2023)
10/13 (76.92%)
$0.42 (2.26%)
63
Hold
$19
$12
1 years 1 months 27 days ago
(27-Sep-2023)
4/7 (57.14%)
$0.42 (2.26%)
111
Hold
$19
$13
1 years 1 months 27 days ago
(27-Sep-2023)
12/25 (48%)
$0.42 (2.26%)
39
Hold
$19
$20
1 years 1 months 27 days ago
(27-Sep-2023)
3/8 (37.5%)
$0.42 (2.26%)
63
Hold
$19
$15
1 years 1 months 27 days ago
(27-Sep-2023)
3/13 (23.08%)
$0.42 (2.26%)
57
What Year was the first public recommendation made by Jonathan Eckard?